Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jade Pharma To Set Up Biopharmaceutical Base In Jiangxi

This article was originally published in PharmAsia News

Executive Summary

U.S.-listed Jade Pharmahas signed a letter of intent with Sanghai Economic and Technological Development Zone in Jiangxi province to set up the company's biopharmaceutical projects base in Sanghai with an investment of $150 million. The project's first phase, with $25 million in funding, will cover the construction of a R&D base this year. The second phase, to begin in 2010, will include the building of a cultivation center for anticancer plants. Jade Pharma is a pharmaceutical company that focuses on early diagnostic testing technology for cancer and other diseases. Jade also engages in R&D, production and trading of biopharmaceutical products and medicines. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071134

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel